Alkem Laboratories Ltd Share Price
₹5,185.00
+40.00+0.78% (1D)
As on 20 Nov 2026 at 15:53
As of 20 Nov 2026 at 15:53, Alkem Laboratories Ltd is trading at ₹5,185.00. The 52-week range stands at ₹4,811.00–₹5,933.50, with a market cap of ₹61.80 thousand crore. At a P/E of 27.39 and a dividend yield of 1.03%, it is a large-cap stock in the Pharmaceuticals sector.
ALKEM Price Chart
Market Cap
₹61.80K Cr
PE Ratio
27.39
ROCE
19.13%
Alkem Laboratories Ltd Performance
Alkem Laboratories Ltd Fundamentals
Know MoreMarket Cap₹61.80K Cr
ROE14.28%
P/E Ratio (TTM)27.39
EPS (TTM)₹188.71
P/B Ratio4.06
Dividend Yield1.03%
Industry P/E91.72
Book Value₹1,271.82
Debt to Equity0.01
Face Value₹2
Alkem Laboratories Ltd Shareholding Pattern
Know MoreAlkem Laboratories Ltd Financial Statements
Know MoreNo data for this view.
Alkem Laboratories Ltd Peer Comparison
Know More| Stocks | LTP(₹) | Market Cap(Cr) | 52 Week Low-High(₹) |
|---|---|---|---|
₹1,885.10 -14.90(-0.78%) | 4,52,298.6 | 1,583.7 - 2,046.9 | |
₹4,698.80 87.80(+1.90%) | 1,78,727.3 | 3,672.3 - 5,250.0 | |
₹1,390.50 -10.40(-0.74%) | 1,16,144.5 | 1,101.0 - 1,414.9 | |
₹1,414.95 -3.55(-0.25%) | 1,14,312.1 | 1,165.7 - 1,539.7 | |
₹2,010.00 11.20(+0.56%) | 91,915.9 | 1,892.9 - 2,529.5 |
About Alkem Laboratories
Company background unavailable.
Parent Organisation—
Founded1973
Managing DirectorSANDEEP SINGH
NSE SymbolALKEM
Alkem Laboratories Ltd Resistance and Support levels
Alkem Laboratories Ltd Technicals
Current Price
₹5,185.00 ₹40.00 (+0.78%)
10
2
- 20 Day0.3%
- 50 Day0.8%
- 100 Day2.1%
- 200 Day3.2%
Alkem Laboratories Ltd Latest News
View More12 NOV 2026 | Thursday
Alkem Laboratories will reopen trading November 16 after reporting financial results
12 NOV 2026 | Thursday
Alkem Laboratories appoints Gopal Kothari as CFO, effective December 2, 2026
09 NOV 2026 | Monday
Alkem Laboratories Ltd spurts 1.46%, gains for third straight session
08 NOV 2026 | Sunday
Alkem Laboratories forms Alkem Pharma Company joint venture in Saudi Arabia
05 NOV 2026 | Thursday
Alkem Laboratories appoints Dr. Amrut Naik as CEO, effective November 11, 2026
04 NOV 2026 | Wednesday
Alkem Laboratories to review quarterly and half-year financial results on November 12
03 NOV 2026 | Tuesday
Alkem Laboratories names Dr. Amrut Naik CEO, effective November 2026
21 OCT 2026 | Wednesday
Alkem Laboratories Ltd drops for fifth straight session
12 OCT 2026 | Monday
Alkem Laboratories appoints Laxmikant Tiwari and Nilesh Vartak to senior roles
22 SEPT 2026 | Tuesday
Alkem Laboratories closes trading window ahead of September 2026 financial results release
2026
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Board MeetingAnnounced
DividendFinal₹10.00Per share
Quarterly ResultRelease dateCheck Latest financial
DividendInterim₹43.00Per share
Quarterly ResultRelease dateCheck Latest financial